Our Pricing

Mounjaro Oxted: Your Complete Guide to Accessing Tirzepatide Weight Loss Treatment

Published: 3 October 2026

Residents searching for Mounjaro Oxted now have convenient access to this clinically proven weight loss treatment through Cured Pharmacy, a fully registered UK online pharmacy service. Mounjaro (tirzepatide) has demonstrated exceptional efficacy in clinical trials, with patients achieving average weight reductions of up to 22.5% over 72 weeks in the SURPASS-2 trial [1]. Our service provides Oxted residents with transparent pricing from £124.99, free online prescriber consultations, and discreet next-day delivery, eliminating the need for in-person pharmacy visits.

What Is Mounjaro Oxted and How Does It Work?

Mounjaro Oxted refers to the availability of tirzepatide weight loss injections for residents in the Oxted area through registered UK pharmacy services like Cured Pharmacy. Tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it activates two separate hormone pathways that regulate appetite, blood sugar control, and energy metabolism [2]. This dual mechanism distinguishes Mounjaro from single-pathway medications like semaglutide, potentially explaining its superior weight loss outcomes in head-to-head clinical comparisons.

The medication works by mimicking natural gut hormones that signal fullness to the brain, slow gastric emptying to prolong satiety after meals, and improve insulin sensitivity. In the landmark SURMOUNT-1 trial involving over 2,500 participants without diabetes, those receiving the highest maintenance dose (15mg weekly) achieved an average weight reduction of 22.5% from baseline over 72 weeks, compared to 2.4% with placebo [1]. These results represent some of the most substantial weight loss outcomes ever documented in obesity pharmacotherapy trials.

Mounjaro Oxted Pricing and Ordering Process

Cured Pharmacy offers Mounjaro Oxted at £124.99 for the starting dose pack, with transparent pricing displayed before you begin your clinical assessment. New patients can Save £20 using code Weightlossnew on their first order, reducing the initial cost to £124.99. Unlike some services that hide pricing until after consultation, we believe Oxted residents deserve upfront clarity about treatment costs.

The ordering process is straightforward and fully compliant with UK pharmacy regulations. You complete a brief online consultation (typically under 3 minutes) that is reviewed by our UK-registered prescribers. If Mounjaro is deemed clinically appropriate for your circumstances, your prescription is issued and the medication is dispensed from our GPhC-registered pharmacy (registration number 9012511). Orders placed before 3pm typically arrive the next working day in completely discreet packaging, with no external indication of contents.

Subscription Options for Mounjaro Oxted

We offer flexible subscription plans for Mounjaro Oxted patients who require ongoing treatment. Tirzepatide therapy typically follows a dose escalation schedule over several months, starting at 2.5mg weekly and potentially increasing to 5mg, 7.5mg, 10mg, 12.5mg, or 15mg based on individual response and tolerability [3]. Our subscription service ensures timely delivery of each dose tier without requiring you to manually reorder, though you maintain full control to pause or cancel at any time. Superintendent pharmacist Tarun Kumar (GPhC 2233073) and our clinical team provide ongoing support throughout your treatment journey.

Clinical Evidence Supporting Mounjaro Oxted Treatment

The clinical foundation for offering Mounjaro Oxted rests on robust evidence from the SURMOUNT and SURPASS trial programmes, which collectively enrolled over 10,000 participants. The SURMOUNT-1 trial specifically examined tirzepatide for weight management in adults without diabetes, demonstrating dose-dependent weight reductions ranging from 15% (5mg dose) to 22.5% (15mg dose) at 72 weeks [1]. Importantly, 91% of participants on the highest dose achieved at least 5% weight loss, and 57% achieved at least 20% weight loss, thresholds associated with significant metabolic health improvements.

Beyond weight reduction, Mounjaro demonstrated favourable effects on cardiometabolic risk markers. Participants experienced average reductions in systolic blood pressure of 6-7 mmHg, improvements in lipid profiles, and enhanced glycaemic control even in those without diabetes [2]. The medication received MHRA approval for weight management in the UK in November 2023, following comprehensive regulatory review of its safety and efficacy profile. Common side effects include nausea, diarrhoea, and constipation, which typically diminish as treatment continues and are mitigated by the gradual dose escalation protocol [3].

Who Can Access Mounjaro Oxted Services?

Mounjaro Oxted is available to adults with a body mass index (BMI) of 30 kg/m² or above, or 27 kg/m² or above with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or obstructive sleep apnoea. During your online consultation, our UK-registered prescribers assess your medical history, current medications, and treatment goals to determine suitability. Certain contraindications apply, including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease.

Pregnant or breastfeeding individuals cannot use Mounjaro, and women of childbearing potential should use reliable contraception during treatment and for at least two months after discontinuation [4]. The prescriber review ensures Mounjaro is both safe and appropriate for your individual circumstances. If tirzepatide is not suitable, our clinical team may recommend alternative weight management options such as Wegovy (semaglutide), Saxenda (liraglutide), or orlistat-based treatments, all available through our service.

Mounjaro Oxted for Different Patient Groups

Clinical trials included diverse patient populations, though certain groups require additional consideration. Older adults over 65 can use Mounjaro Oxted, though dose adjustments may be warranted based on renal function and overall health status. Patients with mild to moderate renal impairment can typically use tirzepatide without dose modification, but those with severe renal impairment or end-stage renal disease should discuss alternative options with their prescriber [3]. Our clinical team reviews each case individually to ensure treatment safety and optimise outcomes for Oxted residents across different demographic and health profiles.

How to Use Mounjaro Oxted Injections Correctly

Mounjaro arrives as a pre-filled injection device that administers a precise dose subcutaneously (under the skin) once weekly. Injection sites include the abdomen, thigh, or upper arm, and should be rotated each week to minimise injection site reactions. The medication does not require refrigeration during use (store below 30°C), though unused devices should be refrigerated between 2-8°C. Each device is single-use and should be disposed of in a sharps container after administration.

Timing consistency improves treatment adherence—choose a day of the week that suits your routine and inject at approximately the same time each week. Mounjaro Oxted can be taken with or without food. If you miss a dose and the next scheduled dose is more than 4 days away, take the missed dose as soon as you remember; if less than 4 days remain, skip the missed dose and resume your regular schedule [4]. Never double up doses to compensate for a missed injection. Detailed administration instructions are included with each delivery, and our pharmacy team is available at (+44) 116 4646009 for any questions.

Mounjaro Oxted Delivery and Ongoing Support

Cured Pharmacy provides discreet, next-day delivery to Oxted addresses for orders placed before 3pm on working days. All packaging is completely plain with no external indication of contents, ensuring complete privacy. We use tracked courier services so you can monitor your delivery in real-time and plan to receive your medication securely.

Beyond the initial supply, our service includes ongoing clinical support throughout your Mounjaro Oxted treatment journey. As you progress through dose escalation phases, our prescribers review your response, tolerability, and any side effects to optimise your regimen. Weight loss typically becomes evident within the first month, with progressive reductions continuing over 12-18 months of treatment [1]. Regular monitoring helps identify if dose adjustments are needed or if additional lifestyle interventions would enhance outcomes. Our goal is not simply to dispense medication, but to support sustainable, clinically meaningful weight loss for Oxted residents through comprehensive pharmaceutical care.

Long-Term Treatment Planning for Mounjaro Oxted

Clinical guidance suggests Mounjaro should be discontinued if patients do not achieve at least 5% weight loss after 16 weeks at the maximum tolerated dose, as continued use is unlikely to provide meaningful benefit [3]. For those who respond well, treatment duration varies based on individual goals and clinical response. Some patients achieve their target weight and successfully transition to maintenance strategies, while others benefit from longer-term therapy to sustain weight loss and metabolic improvements. Our Oxted prescribers work collaboratively with you to develop a personalised treatment timeline that aligns with your health objectives and integrates with broader lifestyle modifications including nutrition and physical activity changes.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Bunck, M. C. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 3 October 2026]
2. Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., ... & SURPASS-2 Investigators. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 3 October 2026]
3. Electronic Medicines Compendium. (2024). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/14298 [accessed 3 October 2026]
4. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro (tirzepatide): Approved for chronic weight management in the UK. Drug Safety Update, 17(4), 2-3. [accessed 3 October 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 3 October 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 3 October 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 3 October 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.